Comparative inhibition by oral bilastine, parenteral dexchlorpheniramine, and a new bilastine parenteral (i.v. and i.m.) formulation of histamine-induced wheal and flare response: A randomised phase I trial
European Journal of Pharmaceutical Sciences · 2024-12 · 203 · 106900
DOI: 10.1016/j.ejps.2024.106900 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift European Journal of Pharmaceutical Sciences, 2024-12. Verfasst von Jimena Coimbra und 7 weiteren Autor:innen. Beteiligte Einrichtung: Centre d'Investigació de Medicaments (CIM), Institut de Recerca Sant Pau (IR SANT PAU), Barcelona, Spain. Hauptthemen laut MEDLINE: Chlorpheniramine, Benzimidazoles, Cross-Over Studies, Histamine. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Government of the Basque Country.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre d'Investigació de Medicaments (CIM), Institut de Recerca Sant Pau (IR SANT PAU), Barcelona, Spain.
- CIBER Epidemiología y Salud Pública (CIBERESP), Spain, Clinical Epidemiology and Public Health Department, Hospital de la Santa Creu i Santa Pau, Barcelona, Spain, Universitat Autónoma de Barcelona (UAB), Bellaterra, Sp…
- Clinical Pharmacology Department, Hospital de la Santa Creu i Sant Pau, Centre d'Investigació de Medicaments (CIM), Institut de Recerca Sant Pau (IR SANT PAU), Pharmacology and Therapeutics Department, Universitat Autón…
- Medical Department, FAES FARMA S. A., Leioa (Vizcaya), Spain.
- Medical Department, FAES FARMA S. A., Leioa (Vizcaya), Spain. Electronic address: csanchez@faes.es.
Förderung
- Government of the Basque Country
Zitieren
APA
Coimbra, J., Puntes, M., Molina, P., Gich, I., Antonijoan, R., Gilaberte, I., Arranz, P., & Sánchez, C. (2024). Comparative inhibition by oral bilastine, parenteral dexchlorpheniramine, and a new bilastine parenteral (i.v. and i.m.) formulation of histamine-induced wheal and flare response: A randomised phase I trial. European Journal of Pharmaceutical Sciences, 203, 106900. https://doi.org/10.1016/j.ejps.2024.106900
Vancouver
Coimbra J, Puntes M, Molina P, Gich I, Antonijoan R, Gilaberte I, et al. Comparative inhibition by oral bilastine, parenteral dexchlorpheniramine, and a new bilastine parenteral (i.v. and i.m.) formulation of histamine-induced wheal and flare response: A randomised phase I trial. European Journal of Pharmaceutical Sciences. 2024;203:106900. doi:10.1016/j.ejps.2024.106900
BibTeX
@article{Coimbra2024,
author = {Coimbra, Jimena and Puntes, Montserrat and Molina, Pol and Gich, Ignasi and Antonijoan, Rosa and Gilaberte, Inmaculada and Arranz, Paula and Sánchez, Carlos},
title = {Comparative inhibition by oral bilastine, parenteral dexchlorpheniramine, and a new bilastine parenteral (i.v. and i.m.) formulation of histamine-induced wheal and flare response: A randomised phase I trial},
journal = {European Journal of Pharmaceutical Sciences},
year = {2024},
volume = {203},
pages = {106900},
doi = {10.1016/j.ejps.2024.106900}
}
EUVIMED